Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells
The Prostate, 05/17/2012Golovine KV et al.
The investigation demonstrates for the first time that piperlongumine (PL) induces rapid depletion of the androgen receptor in prostate cancer cells. As such, PL may afford novel opportunities for both prevention and treatment of prostatic malignancy.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.